Bidil

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2016
05101520022016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
June 2007 marked the second anniversary of the Food and Drug Administration (FDA)’s approval of BiDil, the first drug to be… (More)
  • table 3
Is this relevant?
2008
2008
This paper explores events surrounding the US Food and Drug Administration's formal approval of the heart failure drug BiDil in… (More)
Is this relevant?
2008
2008
BiDil, a drug approved in 2005 by the FDA only for African Americans, was seen by many as almost reparations for the horrors of… (More)
Is this relevant?
2006
2006
Isosorbide and hydralazine in a fixed-dose combination (BiDil) has provoked controversy as the first drug approved by the Food… (More)
Is this relevant?
2006
2006
In a recent Health Affairs Web Exclusive, Pamela Sankar and Jonathan Kahn argue against the Food and Drug Administration's… (More)
Is this relevant?
2006
2006
The approval of BiDil as an adjunct treatment in self-identified blacks with heart failure raises questions regarding the… (More)
Is this relevant?
Review
2006
Review
2006
This article endeavors to place into context recent developments surrounding the United States Food and Drug Administration… (More)
Is this relevant?
2005
2005
As expected, the launch of the first racially targeted drug, BiDil (isosorbide/hydralzaine; NitroMed), has spawned tremendous… (More)
Is this relevant?
2005
2005
  • Illuminating BiDil
  • Nature Biotechnology
  • 2005
903 Illuminating BiDil BiDil is a recently approved therapy indicated for congestive heart failure patients already taking… (More)
Is this relevant?